Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Aktis Oncology, Inc. (AKTS) vs. Competitors

43 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
AKTSAktis Oncology, Inc.$16.62$924.40M-10.45-25.80%Strong BuyUnlock the AKTS analyst price target with TipRanks PremiumAKTSUnlock the AKTS top-analyst price target with TipRanks Premium
IOVAIovance Biotherapeutics$7.76$3.59B-14.64221.99%Strong BuyUnlock the IOVA analyst price target with TipRanks PremiumAKTS vs IOVAUnlock the IOVA top-analyst price target with TipRanks Premium
ZYMEZymeworks$26.24$1.83B39.1641.84%Strong BuyUnlock the ZYME analyst price target with TipRanks PremiumAKTS vs ZYMEUnlock the ZYME top-analyst price target with TipRanks Premium
ORICOric Pharmaceuticals$7.86$814.71M-5.82-35.52%Strong BuyUnlock the ORIC analyst price target with TipRanks PremiumAKTS vs ORICUnlock the ORIC top-analyst price target with TipRanks Premium
IMCRImmunocore Holdings$29.94$1.55B-47.31-15.35%Moderate BuyUnlock the IMCR analyst price target with TipRanks PremiumAKTS vs IMCRUnlock the IMCR top-analyst price target with TipRanks Premium
NBTXNanobiotix$30.66$1.57B-25.3651.23%Moderate BuyUnlock the NBTX analyst price target with TipRanks PremiumAKTS vs NBTXUnlock the NBTX top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%500%600%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
AKTSAktis Oncology, Inc.16.62-5.78-25.80%
IOVAIovance Biotherapeutics7.765.34220.66%
ZYMEZymeworks26.242.349.79%
ORICOric Pharmaceuticals7.86-4.20-34.83%
IMCRImmunocore Holdings29.94-6.63-18.13%
NBTXNanobiotix30.668.7740.04%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts